TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06246136: A Prospective, Multicenter, Randomized Clinical Trial to Evaluate the Safety and Effectiveness of ELIOS vs Competitor in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

Sponsor: Elios Vision, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 194 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,606,800

Rescue Site Savings

+$4,349,200

Unlock Full NCT06246136 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06246136 Rescue Dossier →